NuCana Stock (NASDAQ: NCNA) stock price, news, charts, stock research, profile.
Open | $4.010 |
Close | $4.000 |
Volume / Avg. | 37.271K / 71.583K |
Day Range | 3.820 - 4.130 |
52 Wk Range | 3.400 - 23.750 |
Market Cap | $8.056M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 29 |
Short Interest | 10.06% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of NuCana (NASDAQ: NCNA) through any online brokerage.
Other companies in NuCana’s space includes: Virios Therapeutics (NASDAQ:VIRI), Can Fite Biofarma (AMEX:CANF), BioRestorative Therapies (NASDAQ:BRTX), Longeveron (NASDAQ:LGVN) and Trevena (NASDAQ:TRVN).
The latest price target for NuCana (NASDAQ: NCNA) was reported by Oppenheimer on Monday, April 1, 2024. The analyst firm set a price target for 4.00 expecting NCNA to rise to within 12 months (a possible 4.99% upside). 5 analyst firms have reported ratings in the last year.
The stock price for NuCana (NASDAQ: NCNA) is $3.81 last updated April 22, 2024 at 8:18 AM EDT.
There are no upcoming dividends for NuCana.
NuCana’s Q1 earnings are confirmed for Wednesday, May 15, 2024.
There is no upcoming split for NuCana.
NuCana is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.